Skip to main content
FATE logo

FATE · Fate Therapeutics Inc

Track FATE — free
$2.48 +0.06 (+2.48%) At close · Sep 4
Market Cap
$297.15M
Shares
119.82M

Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.

Date Member Type Amount
2023-01-31 Daniel Goldman Sell ST · Fate Therapeutics, Inc. (FATE) $1K - $15K
Showing 1–1 of 1 trades
Key facts CIK 1434316 CUSIP 31189P102 13F (30d) 104 filings 104 filers Visit website Investor relations